Serum metabonomics study of colorectal cancer patients with stasis and poison obstruction syndrome or Qi and blood deficiency syndrome based on LC-MS
邹敏 1王雅楠 1归明彬 1李沛菡 1高华 1高峰1
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 中国人民解放军联勤保障部队第九四○医院结直肠肛门外科 甘肃兰州 730050
折叠
摘要
目的 探讨瘀毒内阻证和气血两虚证结直肠癌患者血清代谢物差异.方法 纳入30例结直肠癌患者,分为瘀毒内阻证组(n=17)和气血两虚证组(n=13).采用液相色谱-质谱联用(liquid chromatography-mass spectrometry,LC-MS)技术检测血清代谢谱,使用主成分分析(principal component analysis,PCA)、偏最小二乘判别分析(partial least squares-discriminant analysis,PLS-DA)和正交-偏最小二乘判别分析(orthogonal partial least squares discriminant analysis,OPLS-DA)进行多元统计分析,并结合受试者操作特征曲线(receiver operating characteristic curve,ROC),计算ROC曲线下面积(area under curve,AUC)值,进一步评估代谢物对证型诊断的敏感度和特异度,对差异代谢物进行层次聚类分析得到热图并通过京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)数据库寻找出共同富集的代谢通路.结果 筛选出差异代谢物13种,其中5种显著上调,8种显著下调,其中有2种差异代谢物AUC值大于0.9,除此之外,还有6种差异代谢物AUC值大于0.8.4-O-β-D-吡喃葡萄糖基-D-甘露聚糖、红豆碱、甘露糖、肌苷为气血两虚证敏感代谢物,2-羟基琥珀酸为瘀毒内阻证敏感代谢物.两组的差异代谢物主要富集的信号通路有3个,分别为半乳糖代谢(Galactose metabolism)通路、溶酶体(Lyso-some)通路及C型凝集素受体信号通路(C-type lectin receptor signaling pathway).结论 结直肠癌瘀毒内阻证、气血两虚证患者的代谢物存在显著差异,为结直肠癌患者准确、客观的综合征分化和中医治疗提供了可能.
Abstract
Objectives The purpose of this study was to explore the difference in serum metabolites between patients with colorectal cancer(CRC)with stasis and poison obstruction syndrome or Qi and blood deficiency syndrome.Methods There are thirty patients with CRC were divided into the stasis and poison obstruction syndrome(SPOS group,n=17)and the Qi and blood deficiency syndrome(QBDS group,n=13).Serum metabolic spectrum was detected by liquid chromatography-mass spectrometry,principal component analysis,partial least squares discriminant analysis,and orthogo-nal partial least squares discriminant analysis,and combined with receiver operating characteristic curve,the area under the curve(AUC)was calculated to further evaluate the sensitivity and specificity of metabolites to syndrome diagnosis.The differential metabolites were analyzed by hierarchical clustering to obtain heat maps,and the co-enriched metabolic pathways were found through the Kyoto Encyclopedia of Genes and Genomes(KEGG)database.Results There are thir-teen kinds of differential metabolites were screened,of which five were significantly up-regulated and eight were signifi-cantly down-regulated,among which two had AUC values greater than 0.9 and another six had AUC values greater than 0.8.4-O-beta-D-Glucopyranosyl-D-mannose,abrine,D-Mannose,inosine were sensitive metabolites in the QBDS group,and 2-Oxosuccinamate was sensitive metabolite in the SPOS group.There are three signal pathways in which the iconic differ-ential metabolites in these two groups are mainly enriched,namely,Galactose metabolism pathway,Lysosome pathway and C-type lectin receptor signaling pathway.Conclusion There are significant differences in metabolites between the QBDS group and the SPOS group,which provides the possibility for accurate and objective syndrome differentiation and traditional chinese medicine treatment of CRC patients.
关键词
结直肠癌/代谢组学/液相色谱-质谱联用/瘀毒内阻证/气血两虚证
Key words
colorectal cancer/metabonomics/liquid chromatography-mass spectrometry/stasis and poison obstruction syn-drome/Qi and blood deficiency syndrome
维普
万方数据